Daan Gene Co., Ltd. (SHE:002030)
6.15
+0.12 (1.99%)
At close: Mar 6, 2026
Daan Gene Market Cap
Daan Gene has a market cap or net worth of 8.63 billion as of March 6, 2026. Its market cap has increased by 7.89% in one year.
Market Cap
8.63B
Enterprise Value
8.11B
Revenue
765.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.15
Market Cap Chart
Since August 9, 2004, Daan Gene's market cap has increased from 1.30B to 8.63B, an increase of 563.10%. That is a compound annual growth rate of 9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.63B | 3.19% |
| Dec 31, 2025 | 8.36B | 4.93% |
| Dec 31, 2024 | 7.97B | -41.32% |
| Dec 29, 2023 | 13.59B | -37.79% |
| Dec 30, 2022 | 21.84B | -22.43% |
| Dec 31, 2021 | 28.15B | -6.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 9.39B |
| Bio-Thera Solutions | 8.90B |
| Shanghai Medicilon | 8.73B |
| Sino Biological,Inc. | 8.50B |
| Jiangxi Fushine Pharmaceutical | 8.22B |
| Chengdu Kanghua Biological Products | 7.97B |
| Youcare Pharmaceutical Group | 7.94B |
| Suzhou Fengbei Biotech Stock | 7.94B |